Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus

Clinical trial NCT00391209 · COMPLETED

Trial details

NCT number: NCT00391209
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2006-10-01
Primary completion: 2008-05-01
Enrollment: 379

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.